The Swiss stock market ended Wednesday's session unchanged, halting its recent four day winning streak. The recent run up brought the market to a new high for the year during yesterday's session.
Traders were in a cautious mood ahead of speeches from both Federal Reserve Chair Janet Yellen and European Central Bank President Mario Draghi. Investors are also looking forward to the release of the U.S. jobs report for September on Friday.
The Swiss Market Index increased by 0.00 percent Wednesday and finished at 9,283.97. The Swiss Leader Index climbed 0.06 percent and the Swiss Performance Index added 0.04 percent.
Financial stocks were under pressure Wednesday. Swiss Life weakened by 0.8 percent, Zurich Insurance fell 0.6 percent and Swiss Re lost 0.5 percent. Julius Baer declined 1.0 percent and UBS (surrendered 0.5 percent. Meanwhile, Credit Suisse rose 0.2 percent.
Kuehne + Nagel decreased by 0.9 percent. JPMorgan increased its price target on the stock, but confirmed its "Underweight" rating.
Vifor Pharma was among the best performing stocks of the session, with an increase of 2.0 percent. Lonza also finished higher by 1.6 percent. Sonova gained 1.2 percent after it received a "Buy" rating from Deutsche Bank.
Index heavyweight Nestlé advanced 0.1 percent, while Novartis and Roche dipped by 0.1 percent each.
For comments and feedback contact: editorial@rttnews.com
Market Analysis
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.